Drug Approvals
🇺🇸 FDA Page 17FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 193–204 of 665 articles
14 New Weight Loss Drugs: Regulatory Updates and Implications
2025 Drug Approvals: Biopharma's Resilience Amidst Challenges
Commissioner's National Priority Voucher Pilot Program: Clinical Trials Insights
Biotech Stocks Facing FDA Decision in June 2026: Key Insights
FDA Considers Easing Restrictions on Unproven Peptides
FDA Approvals in Oncology: January-March 2026
Eli Lilly Acquires Centessa Pharmaceuticals: Market Analysis
FDA's Permanent Ban on Compounded GLP-1s: What It Means for Pharma
Top Biotech Gainers: CODX, NRXP, NVAX - Clinical Trials Update
Top 10 Takeover Targets of 2026: Market Analysis
FDA Eases Restrictions on Peptides: Implications for Drug Approvals
Sunlight GLP-1 2026: FDA's Decision on Compounded Semaglutide